MABs Issues Research Articles in Vol. 13, No. 1
December 20, 2021
December 20, 2021
MILTON, England, Dec. 20 -- mABs, a peer-reviewed journal that says it features antibody research including cancer and immune-mediated disorders and antibody therapeutics, published research articles, including the following topics, in its Vol. 13, No. 1 edition:
Reports:
* Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
* Agonistic nanobodies and antibodies to human VISTA
. . .
Reports:
* Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
* Agonistic nanobodies and antibodies to human VISTA
. . .
